EU MDR & IVDR Compliance: What Manufacturers Must Know

The European Union Medical Device Regulation (EU MDR, Regulation 2017/745) and the In Vitro Diagnostic Regulation (IVDR, Regulation 2017/746) represent the most significant overhaul of medical device regulation in Europe in over 25 years. Together, they establish a rigorous, risk-proportionate framework governing the design, manufacture, clinical evaluation, market access, and post-market surveillance of medical devices and in vitro diagnostics sold in the EU.

For manufacturers, notified bodies, authorized representatives, and importers, EU MDR and IVDR compliance demands a fundamental transformation of quality systems, technical documentation, clinical evidence standards, and post-market activities. Many organizations have discovered that spreadsheets, paper-based systems, and legacy quality management software cannot support the breadth, depth, and traceability requirements these regulations demand.

This white paper provides a comprehensive overview of EU MDR and IVDR requirements, examines the compliance challenges manufacturers face in 2026, and demonstrates how Cloudtheapp's AI-powered, cloud-native Quality Management System (QMS) helps medical device and IVD manufacturers achieve and sustain full regulatory compliance.

Key stat: As of early 2026, thousands of medical device manufacturers remain in transitional compliance phases under EU MDR and IVDR. Organizations with modern, cloud-based QMS platforms are completing transitions 40-60% faster than those relying on legacy systems. (Source: RAPS Regulatory Focus, 2025)